Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
One Too Many For doTerra: Direct Seller Appeals Third Review Of Essential Oils Advertising In 2020
Oct 28 2020
•
By
Eileen Francis
DoTerra argues NAD attorneys not only discounted reliable evidence but also applied a “prohibitive” legal standard and misconstrued scope of challenge by SC Johnson & Son.
More from Compliance
More from Policy & Regulation